[HTML][HTML] Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement

…, P Kuna, C Ljørring, JL Prieto, HH Villesen - Respiratory …, 2015 - Elsevier
Background Exacerbations are a key outcome in clinical research, providing patient-relevant
information about symptomatic control, health state and disease progression. Generally …

Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial

…, V Backer, P Kuna, L Prieto, H Nolte, HH Villesen… - Jama, 2016 - jamanetwork.com
Importance The house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet is
a potential novel treatment option for HDM allergy–related asthma. Objectives To evaluate …

Cerebral kinetics of oxycodone in conscious sheep

HH Villesen, DJR Foster, RN Upton… - Journal of …, 2006 - Elsevier
Oxycodone is an opioid analgesic that is administered orally or parenterally. The time-course
of opioid action is a function of the systemic kinetics of the opioid, and the rate and extent of …

Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients

HH Villesen, AM Banning, RH Petersen… - … and clinical risk …, 2007 - Taylor & Francis
Background An increased and prolonged duration of pain relief after morphine administration
has been found in elderly patients. Whether this is due to alterations in pharmacokinetics, …

Symptoms and side effects in chronic non‐cancer pain: patient report vs. systematic assessment

…, LL Christrup, J Højsted, HH Villesen… - Acta …, 2011 - Wiley Online Library
Background: Relieving distressing symptoms and managing the side effects of analgesics
are essential in order to improve quality of life and functional capacity in chronic non‐cancer …

Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers

…, NH Jensen, BN Nielsen, U Skram, HH Villesen… - European journal of …, 2007 - Springer
Objective The aim of this investigation was to characterize the pharmacokinetics of
buprenorphine following administration of an intravenous (iv) infusion. To date, the population …

Tolerability of the SQ tree SLIT tablet in adults

AO Birk, JS Andersen, HH Villesen, MA Steffensen… - Clinical Therapeutics, 2017 - Elsevier
… AO Birk, JS Andersen, HH Villesen, and MA Steffensen are employed by ALK. MA Calderon
has received consultancy and lecture fees from ALK, Stallergenes, Merck, Allergopharma, …

Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers

HH Villesen, K Kristensen, SH Hansen… - European journal of …, 2007 - Springer
Villesen … In the present study, the plasma concentration peaks after 50 mg occurred
slightly later than previously published by Villesen et al. (t 1 : 3.5 vs. 2.5; t 2 : 21.3 vs. …

Pharmacokinetics of M6G following intravenous and oral administration in healthy volunteers

HH Villesen, B Hedal, J Engbaek, S Frokjaer… - Acute Pain, 2006 - Elsevier
BACKGROUND: The active metabolite of morphine, morphine-6-glucuronide (M6G), shows
an analgesic effect that is equivalent to morphine. The bioavailability is low (11–13%) when …

Blood–brain distribution of morphine‐6‐glucuronide in sheep

HH Villesen, DJR Foster, RN Upton… - British journal of …, 2006 - Wiley Online Library
Background and purpose: At present there are few data regarding the rate and extent of
brain–blood partitioning of the opioid active metabolite of morphine, morphine‐6‐glucuronide (…